DEDarío Echeverri

Darío Echeverri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Darío Echeverri has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Concomitant Mitral Regurgitation

    by Nicolas Nunez–Ordonez, Maria Jose Rozo, Jaime Cabrales, Dario Echeverri, Carlos Villa-Hincapie, Tomas Chalela, Carlos Obando, Lina Ramirez, Juan Andres Sarmiento, Jose Vicente Alvarez-Martinez, et al.

    Objectives: To describe the clinical outcomes of patients with severe aortic valve stenosis (AS) and concomitant mitral regurgitation (MR) undergoing transcatheter aortic valve replacement (TAVR) Methods: A propensity‐score matched analysis including 267 patients who underwent TAVR between 2009 and 2023. Information on pre‐, intra‐, and postoperative variables was collected. The main outcomes were survival and freedom from readmission for heart failure on long term follow‐up comparing the group with significant MR (sMR) (moderate–severe) vs. the control group. Results: The prevalence of sMR was 22%. TAVR improved the severity of MR in 65% of the patients. There were no significant differences on the main early postoperative outcomes. sMR was not associated with a lower survival on long‐term follow‐up but readmission for heart failure was higher in this group. Conclusions: MR is highly prevalent in patients undergoing TAVR. The procedure has a beneficial effect on the severity of concomitant MR. sMR was not associated with a higher mortality in long‐term follow‐up, patients with sMR experience a significant improvement in symptoms after TAVR although sMR was associated with higher heart failure readmissions.

  • Open Access

    Experiencia multicéntrica de implante valvular aórtico percutáneo discriminada por riesgo en centros de Latinoamérica

    by Gerardo Nau, Ezequiel Zaidel, Marcelo Abud, Fernando Cura, Enrique Rivero, Emer Vitor, Darío Echeverri, Carlos Giuliani, Marcelo Bettinotti, Matías Sztejfman

    Introducción: El implante valvular aórtico percutáneo ha sido valorado en diferentes escenarios del amplio espectro de la población portadora de estenosis aórtica grave sintomática. La elección del tipo de tratamiento parte de una evaluación del riesgo de un equipo multidisciplinario. Objetivos: El objetivo de este estudio fue analizar las características y conocer los resultados de los pacientes sometidos a IVAP en Latinoamérica según el riesgo. Material y métodos: Se incluyeron a partir de marzo de 2009 a diciembre de 2018 pacientes en forma continua del registro multicéntrico latinoamericano de implante valvular aórtico percutáneo. La indicación de implante valvular aórtico percutáneo fue realizada en cada caso por un equipo multidisciplinario local. Se estratifica la población en función del riesgo quirúrgico evaluado por el puntaje STS-PROM. Se definieron tres grupos en función de los puntos de corte del STS-PROM establecidos: riesgo alto (RA, mayor del 8%), riesgo intermedio (RI, entre el 4% y el 8%) y riesgo bajo (RB, menordel 4%). Resultados: Se incluyeron en el análisis 770 pacientes; la mitad era de sexo femenino (50,2%) con una mediana de edad de 81 años (RIC 75,6-85,7). Del total, 230 pacientes (29,8%) fueron incluidos en el grupo AR (STS-PROM medio 11 [9,3-16,7]); 339 pacientes (44%), al riesgo intermedio (STS-PROM medio 6 [4,8-6,71]); y los restantes 201 (26,1%), al bajo riesgo (STS-PROM medio 2,7 [2-3,24]). La proporción de pacientes de bajo riesgo se incrementó a lo largo del período del registro (ptrend 0,011). Se utilizó acceso femoral (95%), y fue percutáneo en el 69% de los pacientes. Se implantaron en el 80% válvulas autoexpandibles. Del total de válvulas implantadas, el 23% (n = 177) resultaron ser reposicionables sin diferencias a través de los grupos. No se evidenciaron diferencias en mortalidad a los 30 días (RA 10,4%, RI 6,48%, RB 5,9%, p: 0,154) Tanto en el RA como en el de RB se observó una reducción de la mortalidad (RA 13,7%-4,1%, p: 0,001; RB 11,7%-0%; p: 0,0023). Conclusiones: La estratificación de riesgo mediante puntajes quirúrgicos continúa representando una guía de gran utilidad, sin embargo la indicación de implante valvular percutáneo en el mundo real incorpora otros factores no contemplados en la puntuación clásica, que modifica nuestras decisiones en la práctica diaria.


  • Open Access

    Income-Based Inequalities in Five-Year Survival after Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention among Formally Employed Adults in Colombia: A Nationwide Cohort Study

    by Andrés Felipe Patiño-Benavidez, Darío Echeverri, Carlos Eduardo Obando López, Nicolás Uribe Valencia, Giancarlo Buitrago

    Background: Myocardial revascularization by coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) lowers mortality, yet long-term outcomes may vary by socioeconomic status despite broadly similar access to care. Objective: To examine the association between income—measured in legal monthly minimum wages (MMW)—and five-year survival after revascularization in formally employed Colombians (2012–2018). Methods: This was a retrospective cohort study using linked national administrative datasets. Income was grouped into quartiles at cohort entry. The primary outcome was five-year mortality. Analyses were stratified by procedure (CABG, PCI). Multivariable Cox models were used to estimate adjusted hazard ratios (aHRs), controlling for age, sex, region, Charlson Comorbidity Index, recent acute myocardial infarction, valve surgery within 30 days, and pre-procedural cardiac rehabilitation (30 days). Socioeconomic gradients were summarized using the Relative Index of Inequality (RII) and the Slope Index of Inequality (SII; absolute difference per 100,000 patients). Results: Among 8,128 patients (mean age = 55.0 ± 9.3 years; 11.3% women), 2,131 underwent CABG and 5,997 underwent PCI. After CABG, five-year mortality was 13.2% in Q1 vs 7.8% in Q4 (p < 0.01); aHRs (vs Q1) were 0.60 (95% CI = 0.40–0.90) for Q2, 0.56 (0.38–0.84) for Q3, and 0.58 (0.38–0.88) for Q4 (all p ≤ 0.01). After PCI, mortality declined from 11.7% (Q1) to 6.5% (Q4) (p < 0.01); only Q4 remained significant after adjustment (aHR = 0.64; 95% CI = 0.49–0.82; p < 0.01). Inequality indices confirmed the gradient: for CABG, SII = 4.14 per 100,000 (95% CI = 3.30–4.98; p < 0.01) and RII = 1.97 (1.17–3.31; p = 0.01); for PCI, SII = 3.13 per 100,000 (2.74–3.52; p < 0.01) and RII = 1.81 (1.32–2.48; p < 0.01). Conclusions: Lower income is associated with worse five-year survival after myocardial revascularization, with larger absolute and relative inequalities after CABG than after PCI.


  • Open Access

    Conscious sedation versus general anesthesia for transcatheter aortic valve implantation: a retrospective study

    by Manuela Téllez-Alarcón, Felix Ramón Montes, Pedro Hurtado, Laura P. Gutiérrez, Jaime R. Cabrales, Jaime Camacho, Darío Echeverri